Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac Tumors

Abstract Objective: Primary cardiac tumors are rare lesions with different histological type. We reviewed our 17 years of experience in the surgical treatment and clinical results of primary non-myxoma cardiac tumors. Methods: Between July 2000 and February 2017, 21 patients with primary cardiac tumor were surgically treated in our institution. The tumors were categorized as benign non-myxomas and malignants. Data including the demographic characteristics, details of the tumor histology and grading, cardiac medical and surgical history, surgical procedure of the patients were obtained from the hospital database. Results: Eleven patients were diagnosed with benign non-myxoma tumor (male/female:7/4), ranging in age from 10 days to 74 years (mean age 30.9±26.5 years). Papillary fibroelastoma was the most frequent type (63.6%). There were two early deaths in benign group (all were rhabdomyoma), and mortality rate was 18%. The mean follow-up period was 69.3±58.7 months (range, 3 to 178 months). All survivals in benign group were free of tumor-related symptoms and tumor relapses. Ten patients were diagnosed with malignant tumor (sarcoma/lymphoma:8/2, male/female:3/7), ranging in age from 14 years to 73 years (mean age 44.7±18.9 years). Total resection could be done in only three (30%) patients. The mean follow-up period was 18.7±24.8 months (range, 0-78 months). Six patients died in the first 10 months. Conclusion: Complete resection of the cardiac tumors, whenever possible, is the main goal of surgery. Surgical resection of benign cardiac tumors is safe, usually curative and provides excellent long-term prognosis. On the contrary, malignant cardiac tumors still remain highly lethal.

Saved in:
Bibliographic Details
Main Authors: Boyacıoğlu,Kamil, Ak,Adnan, Dönmez,Arzu Antal, Çayhan,Burçin, Aksüt,Mehmet, Tunçer,Mehmet Altuğ
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Cirurgia Cardiovascular 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382018000200162
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0102-76382018000200162
record_format ojs
spelling oai:scielo:S0102-763820180002001622018-06-06Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac TumorsBoyacıoğlu,KamilAk,AdnanDönmez,Arzu AntalÇayhan,BurçinAksüt,MehmetTunçer,Mehmet Altuğ Heart Neoplasm Cardiovascular Surgical Procedures Treatment Outcome Abstract Objective: Primary cardiac tumors are rare lesions with different histological type. We reviewed our 17 years of experience in the surgical treatment and clinical results of primary non-myxoma cardiac tumors. Methods: Between July 2000 and February 2017, 21 patients with primary cardiac tumor were surgically treated in our institution. The tumors were categorized as benign non-myxomas and malignants. Data including the demographic characteristics, details of the tumor histology and grading, cardiac medical and surgical history, surgical procedure of the patients were obtained from the hospital database. Results: Eleven patients were diagnosed with benign non-myxoma tumor (male/female:7/4), ranging in age from 10 days to 74 years (mean age 30.9±26.5 years). Papillary fibroelastoma was the most frequent type (63.6%). There were two early deaths in benign group (all were rhabdomyoma), and mortality rate was 18%. The mean follow-up period was 69.3±58.7 months (range, 3 to 178 months). All survivals in benign group were free of tumor-related symptoms and tumor relapses. Ten patients were diagnosed with malignant tumor (sarcoma/lymphoma:8/2, male/female:3/7), ranging in age from 14 years to 73 years (mean age 44.7±18.9 years). Total resection could be done in only three (30%) patients. The mean follow-up period was 18.7±24.8 months (range, 0-78 months). Six patients died in the first 10 months. Conclusion: Complete resection of the cardiac tumors, whenever possible, is the main goal of surgery. Surgical resection of benign cardiac tumors is safe, usually curative and provides excellent long-term prognosis. On the contrary, malignant cardiac tumors still remain highly lethal.info:eu-repo/semantics/openAccessSociedade Brasileira de Cirurgia CardiovascularBrazilian Journal of Cardiovascular Surgery v.33 n.2 20182018-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382018000200162en10.21470/1678-9741-2017-0152
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Boyacıoğlu,Kamil
Ak,Adnan
Dönmez,Arzu Antal
Çayhan,Burçin
Aksüt,Mehmet
Tunçer,Mehmet Altuğ
spellingShingle Boyacıoğlu,Kamil
Ak,Adnan
Dönmez,Arzu Antal
Çayhan,Burçin
Aksüt,Mehmet
Tunçer,Mehmet Altuğ
Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac Tumors
author_facet Boyacıoğlu,Kamil
Ak,Adnan
Dönmez,Arzu Antal
Çayhan,Burçin
Aksüt,Mehmet
Tunçer,Mehmet Altuğ
author_sort Boyacıoğlu,Kamil
title Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac Tumors
title_short Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac Tumors
title_full Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac Tumors
title_fullStr Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac Tumors
title_full_unstemmed Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac Tumors
title_sort outcomes after surgical resection of primary non-myxoma cardiac tumors
description Abstract Objective: Primary cardiac tumors are rare lesions with different histological type. We reviewed our 17 years of experience in the surgical treatment and clinical results of primary non-myxoma cardiac tumors. Methods: Between July 2000 and February 2017, 21 patients with primary cardiac tumor were surgically treated in our institution. The tumors were categorized as benign non-myxomas and malignants. Data including the demographic characteristics, details of the tumor histology and grading, cardiac medical and surgical history, surgical procedure of the patients were obtained from the hospital database. Results: Eleven patients were diagnosed with benign non-myxoma tumor (male/female:7/4), ranging in age from 10 days to 74 years (mean age 30.9±26.5 years). Papillary fibroelastoma was the most frequent type (63.6%). There were two early deaths in benign group (all were rhabdomyoma), and mortality rate was 18%. The mean follow-up period was 69.3±58.7 months (range, 3 to 178 months). All survivals in benign group were free of tumor-related symptoms and tumor relapses. Ten patients were diagnosed with malignant tumor (sarcoma/lymphoma:8/2, male/female:3/7), ranging in age from 14 years to 73 years (mean age 44.7±18.9 years). Total resection could be done in only three (30%) patients. The mean follow-up period was 18.7±24.8 months (range, 0-78 months). Six patients died in the first 10 months. Conclusion: Complete resection of the cardiac tumors, whenever possible, is the main goal of surgery. Surgical resection of benign cardiac tumors is safe, usually curative and provides excellent long-term prognosis. On the contrary, malignant cardiac tumors still remain highly lethal.
publisher Sociedade Brasileira de Cirurgia Cardiovascular
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382018000200162
work_keys_str_mv AT boyacıoglukamil outcomesaftersurgicalresectionofprimarynonmyxomacardiactumors
AT akadnan outcomesaftersurgicalresectionofprimarynonmyxomacardiactumors
AT donmezarzuantal outcomesaftersurgicalresectionofprimarynonmyxomacardiactumors
AT cayhanburcin outcomesaftersurgicalresectionofprimarynonmyxomacardiactumors
AT aksutmehmet outcomesaftersurgicalresectionofprimarynonmyxomacardiactumors
AT tuncermehmetaltug outcomesaftersurgicalresectionofprimarynonmyxomacardiactumors
_version_ 1756429548529909760